If you're a researcher involved in cell counting, you'll know just how important it is for all stages of cellular therapy. In particular, the need for an accurate and consistent cell counting method is crucial for development and manufacturing of CAR-T under GMP/GLP conditions. Assays are required to qualify selected cell counting methods, to ensure robust and consistent cell measurement.
Currently, manual counting using trypan blue and hemacytometer is still the most used method, however, there are several inherent issues that can cause inaccuracy in both cell count and viability.
The Cellometer method has gone through rigorous qualification assays to provide rapid and accurate measurement of PBMCs, splenocytes, and apheresis samples at any stage of CAR-T cell therapy, from patient sample collection, transduction, to patient infusion. In this webinar, Dr. Leo Chan will discuss the advantages of using Cellometer automated cell counters compared to traditional trypan blue and manual counting methods.
Researchers in the immuno-oncology field, researchers in cellular therapy field, general researchers who count cells on a daily basis
This webinar will cover:
Attend the live webinar on Thursday, November 6, at:
Interested, but have a scheduling conflict? Register to watch the webinar on demand at a time more suitable for you.
SelectScience runs 3-4 webinars a month across various scientific topics, discover more of our upcoming webinars>>